Head and Neck Cancer

Aggressive Subtypes of Papillary Thyroid Cancer Deserve Increased Attention

By

Leah Lawrence

Publish Date March 24, 2020

Although papillary thyroid carcinoma subtypes are often lumped together, mortality risk varied greatly across subtypes.

Promising Clinical Activity for RT Plus ICIs in Locally Advanced Head and Neck Cancers

By

Susan Moench, PhD, PA-C

Publish Date March 18, 2020

The majority of patients enrolled in this study were unable to receive cisplatin due to an ear-related comorbidity.

Assessment for Vulnerability Improves Outcomes for Patients With HNC Undergoing Concurrent Chemoradiotherapy

By

Vicki Moore, PhD

Publish Date February 13, 2020

Comprehensive geriatric assessment was shown to effectively identify vulnerability to AEs in patients with HNC across all ages.

Progression-Free Rate With Maintenance Therapy in Some Esophageal or Gastric Cancers May Be Associated With PD-L1 Level

By

Susan Moench, PhD, PA-C

Publish Date February 5, 2020

In this interim analysis, PFS rates were compared in PD-L1–defined biomarker subsets of patients receiving maintenance durvalumab or capecitabine.

No Local Control or OS Benefit Seen With RT Dose Escalation in Inoperable Esophageal Cancer

By

Susan Moench, PhD, PA-C

Publish Date February 3, 2020

In this study, patients were randomly assigned to receive standard-dose RT or standard-dose RT plus an integrated RT boost to the primary tumor.

Mortality Risk in Oropharynx Cancer Varies Based on HPV Status

Publish Date January 16, 2020

Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality.

Routine HPV Testing May Be Warranted for Sinonasal Cancers

Publish Date January 14, 2020

HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival.

Endoscopic Approaches Feasible in Surgery for Sinonasal Cancer

Publish Date January 8, 2020

Overall, 87.4 percent of 239 patients achieved negative margins with endoscopic resection.

U.S. Incidence of Thyroid Cancer Plateaued in 2009

Publish Date January 7, 2020

Significant slowing found in rate of increase from 2009 to 2014, followed by stable rate since 2014.

Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report

Publish Date December 27, 2019

[OncoTargets and Therapy] Researchers outline the case of a 93-year-old female with advanced ATC who received initial treatment with apatinib.